January 26, 2023 Comments Off on New patent for Scynexis drug BREXAFEMME Posted in: Patent Added Annual Drug Patent Expirations for BREXAFEMME Brexafemme is a drug marketed by Scynexis and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent for Scynexis drug BREXAFEMME appeared first on…
January 26, 2023 Comments Off on New patent for Array Biopharma drug BRAFTOVI Posted in: Patent Added Annual Drug Patent Expirations for BRAFTOVI Braftovi is a drug marketed by Array Biopharma Inc and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent for Array Biopharma drug BRAFTOVI appeared first on Dr…